US Stock MarketDetailed Quotes

SGMT Sagimet Biosciences

Watchlist

4.390
-0.150-3.30%

Close Dec 13 16:00 ET

4.390
0.0000.00%

Post 17:19 ET

141.34MMarket Cap-3.77P/E (TTM)

Sagimet Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-404.49%-19.57M

1.50%-5.63M

12.37%-6.21M

2.96%-23.77M

4.96%-7.08M

37.78%-3.88M

6.81%-5.72M

-51.85%-7.08M

-12.81%-24.49M

-7.45M

Net income from continuing operations

-130.11%-14.62M

-19.65%-8.12M

-0.64%-6.63M

8.60%-27.88M

-13.29%-8.15M

14.92%-6.35M

4.46%-6.79M

24.59%-6.59M

-24.78%-30.5M

---7.2M

Operating gains losses

----

-33.33%-4K

----

200.00%2K

-50.00%-3K

----

Other non cash items

5.71%37K

2.94%35K

5.88%36K

6.92%139K

9.09%36K

6.06%35K

6.25%34K

-2.99%130K

--33K

Change In working capital

-1,123.17%-6.01M

7,485.00%1.48M

85.69%-181K

-123.21%-978K

69.86%-280K

-34.78%587K

-103.39%-20K

-134.63%-1.27M

7,761.82%4.21M

---929K

-Change in prepaid assets

-463.27%-4.31M

-0.97%408K

1,829.73%640K

-166.30%-952K

-610.91%-562K

-532.23%-765K

520.41%412K

-102.39%-37K

404.88%1.44M

--110K

-Change in payables and accrued expense

-219.51%-1.66M

375.51%1.09M

34.45%-782K

-95.88%120K

131.84%320K

31.66%1.39M

-155.85%-396K

-155.33%-1.19M

420.54%2.92M

---1.01M

-Change in other current liabilities

0.00%-37K

38.89%-22K

-11.43%-39K

-6.57%-146K

-11.76%-38K

-8.82%-37K

-71.43%-36K

27.08%-35K

4.86%-137K

---34K

Cash from discontinued investing activities

Operating cash flow

-404.49%-19.57M

1.50%-5.63M

12.37%-6.21M

2.96%-23.77M

4.96%-7.08M

37.78%-3.88M

6.81%-5.72M

-51.85%-7.08M

-12.81%-24.49M

---7.45M

Investing cash flow

Cash flow from continuing investing activities

624K

-687.16%-75.16M

-84.54%3M

139.30%12.58M

-460.93%-19.62M

130.88%12.8M

19.4M

-32.01M

5.44M

Net investment purchase and sale

--624K

-687.16%-75.16M

-84.54%3M

139.30%12.58M

-460.93%-19.62M

--0

130.88%12.8M

--19.4M

---32.01M

--5.44M

Cash from discontinued investing activities

Investing cash flow

--624K

-687.16%-75.16M

-84.54%3M

139.30%12.58M

-460.93%-19.62M

--0

130.88%12.8M

--19.4M

---32.01M

--5.44M

Financing cash flow

Cash flow from continuing financing activities

97.03%-27K

77,192.65%104.85M

118,136.99%86.17M

87.21M

-2,933.33%-910K

-1,233.33%-136K

-100.75%-73K

-55K

Net common stock issuance

--0

--105.75M

--89.68M

--3.52M

--86.16M

--0

Proceeds from stock option exercised by employees

--0

--114K

-50.00%6K

--0

--6K

--0

-93.65%12K

--0

Net other financing activities

--0

97.03%-27K

-648.53%-1.02M

-4,038.82%-3.52M

----

---910K

---136K

93.22%-85K

---55K

Cash from discontinued financing activities

Financing cash flow

--0

97.03%-27K

77,192.65%104.85M

118,136.99%86.17M

--0

--87.21M

-2,933.33%-910K

-1,233.33%-136K

-100.75%-73K

---55K

Net cash flow

Beginning cash position

418.47%95.96M

1,332.78%176.78M

47,456.33%75.14M

-99.72%158K

4,466.91%101.84M

314.61%18.51M

-76.31%12.34M

-99.72%158K

-17.42%56.73M

--2.23M

Current changes in cash

-122.73%-18.95M

-1,409.85%-80.82M

734.47%101.64M

232.54%74.98M

-1,188.75%-26.7M

3,830.26%83.33M

112.96%6.17M

361.77%12.18M

-372.58%-56.57M

---2.07M

End cash Position

-24.38%77.01M

418.47%95.96M

1,332.78%176.78M

47,456.33%75.14M

4,466.91%101.84M

314.61%18.51M

-76.31%12.34M

-99.72%158K

--158K

Free cash flow

-404.49%-19.57M

1.50%-5.63M

12.37%-6.21M

2.96%-23.77M

4.96%-7.08M

37.78%-3.88M

6.81%-5.72M

-51.85%-7.08M

-12.81%-24.49M

---7.45M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-404.49%-19.57M	1.50%-5.63M	12.37%-6.21M	2.96%-23.77M	4.96%-7.08M	37.78%-3.88M	6.81%-5.72M	-51.85%-7.08M	-12.81%-24.49M	-7.45M
Net income from continuing operations	-130.11%-14.62M	-19.65%-8.12M	-0.64%-6.63M	8.60%-27.88M	-13.29%-8.15M	14.92%-6.35M	4.46%-6.79M	24.59%-6.59M	-24.78%-30.5M	---7.2M
Operating gains losses	----	----	----	-33.33%-4K	----	----	----	200.00%2K	-50.00%-3K	----
Other non cash items	5.71%37K	2.94%35K	5.88%36K	6.92%139K	9.09%36K	6.06%35K	6.25%34K	6.25%34K	-2.99%130K	--33K
Change In working capital	-1,123.17%-6.01M	7,485.00%1.48M	85.69%-181K	-123.21%-978K	69.86%-280K	-34.78%587K	-103.39%-20K	-134.63%-1.27M	7,761.82%4.21M	---929K
-Change in prepaid assets	-463.27%-4.31M	-0.97%408K	1,829.73%640K	-166.30%-952K	-610.91%-562K	-532.23%-765K	520.41%412K	-102.39%-37K	404.88%1.44M	--110K
-Change in payables and accrued expense	-219.51%-1.66M	375.51%1.09M	34.45%-782K	-95.88%120K	131.84%320K	31.66%1.39M	-155.85%-396K	-155.33%-1.19M	420.54%2.92M	---1.01M
-Change in other current liabilities	0.00%-37K	38.89%-22K	-11.43%-39K	-6.57%-146K	-11.76%-38K	-8.82%-37K	-71.43%-36K	27.08%-35K	4.86%-137K	---34K
Cash from discontinued investing activities
Operating cash flow	-404.49%-19.57M	1.50%-5.63M	12.37%-6.21M	2.96%-23.77M	4.96%-7.08M	37.78%-3.88M	6.81%-5.72M	-51.85%-7.08M	-12.81%-24.49M	---7.45M
Investing cash flow
Cash flow from continuing investing activities	624K	-687.16%-75.16M	-84.54%3M	139.30%12.58M	-460.93%-19.62M	0	130.88%12.8M	19.4M	-32.01M	5.44M
Net investment purchase and sale	--624K	-687.16%-75.16M	-84.54%3M	139.30%12.58M	-460.93%-19.62M	--0	130.88%12.8M	--19.4M	---32.01M	--5.44M
Cash from discontinued investing activities
Investing cash flow	--624K	-687.16%-75.16M	-84.54%3M	139.30%12.58M	-460.93%-19.62M	--0	130.88%12.8M	--19.4M	---32.01M	--5.44M
Financing cash flow
Cash flow from continuing financing activities	0	97.03%-27K	77,192.65%104.85M	118,136.99%86.17M	0	87.21M	-2,933.33%-910K	-1,233.33%-136K	-100.75%-73K	-55K
Net common stock issuance	--0	--0	--105.75M	--89.68M	--3.52M	--86.16M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	--0	--0	--114K	-50.00%6K	--0	--6K	--0	--0	-93.65%12K	--0
Net other financing activities	--0	97.03%-27K	-648.53%-1.02M	-4,038.82%-3.52M	----	----	---910K	---136K	93.22%-85K	---55K
Cash from discontinued financing activities
Financing cash flow	--0	97.03%-27K	77,192.65%104.85M	118,136.99%86.17M	--0	--87.21M	-2,933.33%-910K	-1,233.33%-136K	-100.75%-73K	---55K
Net cash flow
Beginning cash position	418.47%95.96M	1,332.78%176.78M	47,456.33%75.14M	-99.72%158K	4,466.91%101.84M	314.61%18.51M	-76.31%12.34M	-99.72%158K	-17.42%56.73M	--2.23M
Current changes in cash	-122.73%-18.95M	-1,409.85%-80.82M	734.47%101.64M	232.54%74.98M	-1,188.75%-26.7M	3,830.26%83.33M	112.96%6.17M	361.77%12.18M	-372.58%-56.57M	---2.07M
End cash Position	-24.38%77.01M	418.47%95.96M	1,332.78%176.78M	47,456.33%75.14M	47,456.33%75.14M	4,466.91%101.84M	314.61%18.51M	-76.31%12.34M	-99.72%158K	--158K
Free cash flow	-404.49%-19.57M	1.50%-5.63M	12.37%-6.21M	2.96%-23.77M	4.96%-7.08M	37.78%-3.88M	6.81%-5.72M	-51.85%-7.08M	-12.81%-24.49M	---7.45M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data